Opening of the TIDE study at the Strasbourg CHRU!
LATTICE MEDICAL unveils a second stage in the TIDE clinical trial in France!
On 19 October 2023, we announced the opening of the Lille University Hospital as part of the TIDE clinical investigation in France for our MATTISSE device, a resorbable bioprosthesis for breast reconstruction after total mastectomy.
Today, we are delighted to announce the opening of the second centre, the CHRU de Strasbourg – Hôpitaux Universitaires de Strasbourg, and to welcome Prof. Frédéric Bodin as part of our TIDE clinical trial!
For further information: Interested patients can contact the Lille University Hospital at flavien.gautron@chu-lille.fr or gaelle.guyot@chu-lille.fr
Strasbourg University Hospitals:
– Address: Hôpital de Hautepierre, 1 Av. Molière, 67000 Strasbourg Cedex
– Secretariat telephone number: 03.88.11.67.68
– Professor Frédéric Bodin
Two other centres will be opening shortly:
– Institut Gustave Roussy, Paris
– Tenon Hospital AP-HP, Paris
You can find out more about the TIDE clinical trial in our updated press release here 👉 https://www.lattice-medical.com/wp-content/uploads/2023/12/maj-cp-etude-tide-france-07-12.pdfÂ